Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer

Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer

Podrobná bibliografie
Hlavní autoři:	Danielle S. Lewis, Jerry John, Shannon D. Armbruster
Médium:	Článek
Jazyk:	English
Vydáno:	Elsevier 2025-02-01
Edice:	Gynecologic Oncology Reports
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2352578925000141

Podobné jednotky

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
Autor: Yixin Liu, a další
Vydáno: (2019-10-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
Autor: Alex Molassiotis, a další
Vydáno: (2019-06-01)

Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
Autor: Hiroaki Nagano, a další
Vydáno: (2016-03-01)

Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?
Autor: Vijay M Patil, a další
Vydáno: (2014-01-01)

Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers
Autor: Tibor A. Zwimpfer, a další
Vydáno: (2024-01-01)

Platinum drugs and taxanes: can we overcome resistance?
Autor: Elena V. Sazonova, a další
Vydáno: (2021-06-01)

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Autor: Markowska Janina, a další
Vydáno: (2008-01-01)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
Autor: Felisiak-Golabek Anna, a další
Vydáno: (2011-11-01)

Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.
Autor: Seth A Brodie, a další
Vydáno: (2014-01-01)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
Autor: Eun Kyo Joung, a další
Vydáno: (2021-01-01)

The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence
Autor: Chuqing Wu, a další
Vydáno: (2022-11-01)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
Autor: Shirin Kianersi, a další
Vydáno: (2023-01-01)

Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
Autor: Satoshi Imai, a další
Vydáno: (2017-07-01)

Sequential Treatment of Advanced Squamous Lung Cancer:  First-line Gemcitabine +/- platinum Followed by Second-line Taxanes +/- platinum Versus Reverse Sequence
Autor: Jing XU, a další
Vydáno: (2015-05-01)

Cell death in cancer chemotherapy using taxanes
Autor: Ana P. Xu, a další
Vydáno: (2024-01-01)

Beau’s Lines Resulting from Taxane Chemotherapy
Autor: Kumpol Aiempanakit
Vydáno: (2018-10-01)

Genome-wide study of response to platinum, taxane, and combination therapy in ovarian cancer: in vitro phenotypes, inherited variation, and disease recurrence
Autor: Brooke L Fridley, a další
Vydáno: (2016-03-01)

Circulating serum miRNAs predict response to platinum chemotherapy in high‐grade serous ovarian cancer
Autor: Kazuhiro Suzuki, a další
Vydáno: (2024-11-01)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
Autor: Kaname Uno, a další
Vydáno: (2022-03-01)

Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin
Autor: Ryutaro Onaga, a další
Vydáno: (2023-06-01)

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Autor: Irina Larionova, a další
Vydáno: (2024-09-01)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
Autor: Lan G. Coffman, a další
Vydáno: (2022-09-01)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
Autor: T M Anoop, a další
Vydáno: (2022-01-01)

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer
Autor: Sarah J. Taylor, a další
Vydáno: (2024-04-01)

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer.
Autor: Jeyshka M. Reyes-Gonzalez, a další
Vydáno: (2019-03-01)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
Autor: Amelia M. Jernigan, a další
Vydáno: (2013-01-01)

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
Autor: Zheng Feng, a další
Vydáno: (2023-03-01)

Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy
Autor: Jiaxing Lin, a další
Vydáno: (2021-02-01)

Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy studyResearch in context
Autor: Indra A. Van Assche, a další
Vydáno: (2024-12-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
Autor: Sumedha Shastry, a další
Vydáno: (2023-11-01)

Chemotherapy Associated Ovarian Failure
Autor: Davide Mauri, a další
Vydáno: (2020-12-01)

Establishment and Genetic Profiling of Platinum/Taxane Doublet-Resistant Cells Generated by Hybridizing Single Resistant Cells
Autor: Seiji Isonishi, a další
Vydáno: (2022-09-01)

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors
Autor: Robert Knoerl, a další
Vydáno: (2021-09-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
Autor: İlker Selçuk, a další
Vydáno: (2015-04-01)

Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer
Autor: Jiao Liu, a další
Vydáno: (2023-11-01)

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Autor: Carlos J Diaz Osterman, a další
Vydáno: (2019-09-01)

Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
Autor: Chuan-Jen Hung, a další
Vydáno: (2022-10-01)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
Autor: Du Y, a další
Vydáno: (2018-11-01)

Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
Autor: Yue Zhao, a další
Vydáno: (2022-09-01)

Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape.
Autor: Ramya Ganesan, a další
Vydáno: (2023-09-01)